Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARIAD Pharmaceuticals ARIA

Healthcare Biotechnology
"ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788."

Recent & Breaking News (NDAQ:ARIA)

MannKind and Ariad Pharma Under Review: Biotech Companies Receive Drug Approvals

PR Newswire February 22, 2013

ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team

Business Wire February 21, 2013

ARIAD To Present at The RBC Capital Markets Healthcare Conference

Business Wire February 19, 2013

ARIAD to Present at the Leerink Swann Global Healthcare Conference

Business Wire February 8, 2013

The Real Story Behind ONTY, ARIA, SPIL and STSI

Marketwired February 7, 2013

ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2012 Financial Results

Business Wire February 5, 2013

ARIAD Announces Completion of Public Offering

Business Wire January 29, 2013

ARIAD Announces Pricing of Public Offering of Common Stock

Business Wire January 24, 2013

ARIAD Announces Proposed Public Offering of Common Stock

Business Wire January 23, 2013

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Marketwired January 18, 2013

ARIAD and the U.K. National Cancer Research Institute to Collaborate on SPIRIT 3 Clinical Study

Business Wire January 7, 2013

ARIAD to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire January 2, 2013